MANILA (BLOOMBERG) – After losing her son to Covid-19 last year, 79-year-old Tomasa Valdez was desperate to get vaccinated. But on the remote Philippine island of San Salvador, where she lives, there were no shots to be had.
Getting to the mainland, where vaccines were available, meant a boat ride that was arduous at her age and expensive given Ms Valdez’s meagre income from drying sea grass which she sells for less than 100 pesos (S$2.60) a sack.
Help arrived only in December 2021 – 10 months after the Philippines began its national Covid-19 vaccination programme and about a year after Western nations like the United States and the United Kingdom started theirs. Even then, health workers had to travel via a wooden motorised boat, ferrying heavy vaccine storage equipment across the choppy South China Sea.
“Vaccines really have to be brought closer to the people, not the other way around,” said Dr Noel Bueno, who inoculated Ms Valdez. While lack of supply was the biggest threat initially to the vaccination programmes of developing nations, now it is logistics.
Places like the Philippines are now struggling to get shots into the arms of their citizens, millions of whom live in distant archipelagos or on far-flung mountain tops, under-served by roads, transport and basic infrastructure.
Developed countries are getting to the point where they are choosing to live with Covid-19 and treat it as endemic, their hospital systems insulated by higher vaccination rates. But logistical issues continue to bedevil the rollouts of poorer countries, becoming one of the world’s biggest public health challenges as the pandemic enters into its third year.
The Philippines has one of Asia’s lowest vaccination rates, with only about half of its population receiving two shots, according to the Bloomberg Vaccine Tracker. Its limited and costly testing apparatus, fragmented tracing programme and fragile health system have made it hard to stamp out outbreaks despite several economically devastating lockdowns.
In recent days, the country has posted record daily case increases, potentially due to the spread of the ultra-contagious Omicron strain.
The hurdles that developing nations face in widening the reach of their inoculation programmes – which can extend beyond logistics to issues of vaccine hesitancy and social media rumours – are likely to stymie global efforts to contain the virus.
New strains can proliferate in under-vaccinated populations and lengthen the pandemic as the emergence and spread of the Delta and Omicron variants in India and Africa have shown.
Developing nations face a “combination of challenges in hard infrastructure, in the form of trucks, freezers, but also soft infrastructure, in the form of logistics staff, vaccine administrators and adequate planning”, said Dr Prashant Yadav, a senior fellow at the Washington and London-based Centre for Global Development who specialises in supply chains. “But these are all surmountable barriers and we have managed to overcome them for the Ebola vaccine and many other outbreak vaccines.”
While the US government and international agencies have begun efforts to support developing countries, more high-income countries need to step in, he said. “Remote regions have poorer healthcare infrastructure in terms of oxygen, ICU beds, so if someone does get severe Covid the ability to treat them is weaker,” Dr Yadav said. “From that standpoint it becomes important to reach remote areas early.”
To help address these logistical woes, the US, through its Agency for International Development, pledged US$315 million (S$425 million) for mobile vaccination sites for hard-to-reach rural areas, and to invest in cold-storage facilities.
For much of last year, developing nations faced difficulty getting access to the most effective vaccines, which were initially hoarded by Western countries for their own use. The Philippines first relied on shots from China’s Sinovac Biotech, which have been shown to be less potent than the mRNA shots being used in the US, particularly against the Omicron variant.
In recent months, many of its supply problems have eased and the Philippines now has a stockpile of shots. More mRNA vaccines from Pfizer and Moderna are now being administered in the South-east Asian country, particularly to young people.
But its logistical challenges have lingered. Other low- and middle-income nations are grappling with challenges of their own.